HeartSciences Receives Two New Patent Allowances, Expanding its International Patent Portfolio
September 26, 2023 08:00 ET
|
Heart Test Laboratories, Inc.
Southlake, Texas, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an AI-powered medical technology...
HeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I.
September 25, 2023 08:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms
September 21, 2023 08:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an AI-powered medical technology company...
HeartSciences Reports First Quarter Fiscal 2024 Financial Results
September 14, 2023 16:15 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase
September 12, 2023 16:15 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards
September 11, 2023 16:15 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India
September 07, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences Signs Distribution Agreement with FJ Medical, Denmark
August 31, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences’ MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation
August 24, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio
August 17, 2023 09:00 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...